Online Submissions

Already have a Username/Password for Jurnal Sabdariffarma?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines

Instructions for Authors

  1. Jurnal Sabdariffarma received the scientific papers  in the form of research article or literature review related to the field of pharmacy.
  2. Preferred manuscript is that the paper has never been published in other media, both printed and electronic. If it has ever been presented in a scientific meeting, a clear explanation of the name, place and date of the meeting should be given.
  3. Manuscripts are written in standard Indonesian or English with Arial 12, compiled by systematics as described below.
  4. The title is written in a capital letter followed by lowercase letters, bold, not more than 14 words (Indonesian) or 10 words (English), concise and clearly reflect the content of the manuscript.
  5. The author's name should be written without title, given the superscript numbers, followed by the affiliation and specify complete address of corresponding author by e-mail address.
  6. Abstract should be written in English and Indonesian respectively , with a maximum of 200 words, equipped with 3-5 Key Words.
  7. Contents / Body:
    • A research article should compile by the systematics as follows: Introduction, Research Methodology (includes materials, equipment, and methods), Results and Discussion, Conclusions and Recommendations.
    • A literature review or short communication) should follow systematics as Introduction, the sections of sub topics, and Conclusions and/ or Recommendations
  8. References are written sequentially with Arabic numbers (1, 2, 3, ..), in the order of it appearance in the manuscript. It should be written consistently in accordance with the Index Medicus Cummulated and / or the Uniform Requirements for Manuscripts Submitted to Biomedical Journal (Ann Intern Med 1979; 90: 95-99).
  9. Journal abbreviations should follow the provisions in Index Medicus; For journal that are not listed in Index Medicus should not be abbreviated. Example: Cefalu WT, Padridge WM. Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J Neurochem 1985; 45; 1954-1956.
  1. Citation should be written with Arabic number and placed in brackets. Example: ......... compiled by membrane proteins, among others kadherin (5).
  1. Guidance for writing:
    • Typed the title page at the beginning of the script consists of title, author's name and affiliation as well as the name and complete address of corresponding author.
    •  Typed the manuscript in 1 spacing in A4 paper with a top margin of 4 cm, bottom 3 cm, left 4, and right 3 cm. The manuscript may consist of minimum of 8 pages and maximum of 14 pages excluding images/pictures or tables.
    • Tables must be intact, clearly legible, in Microsoft Word format, placed separately on the page after the list of references, given the title and number of tables with Arabic numbers (1, 2, 3 ...).
    • Images/Figures should be made with the format of TIFF, JPG, JPEG, or BMP, or Microsoft Excel format/scatter plot for graphic, submit ted in a separate file with a clear description of the file named according to the number of Figures.
    • Figure legends should be written in MS Word format after the page of tables. Figure legends are numbered with Arabic numbers (1,2,3, ... ).
  2. All manuscripts can be submitted in only at electronic version through
  3. Manuscript received will be screened by the Editor, and then reviewed, the manuscripts may be returned to the author and noted to be revised, and be sent back to the editor  for decision of acceptance for publication.
  4. For clinical research using human subjects should include Ethical clearance.


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Copyright Notice

Please find the rights and licenses in Jurnal Sabdariffarma. By submitting the article/manuscript of the article, the author(s) agree with this policy. No specific document sign-off is required.

  1. License

The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-Share Alike 4.0 International License

  1. Author(s)' Warranties

The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).

  1. User Rights

Sabdariffarma's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Sabdariffarma permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Sabdariffarma on distributing works in the journal and other media of publications.

  1. Rights of Authors

Authors retain all their rights to the published works, such as (but not limited to) the following rights;

  • Copyright and other proprietary rights relating to the article, such as patent rights,
  • The right to use the substance of the article in own future works, including lectures and books,
  • The right to reproduce the article for own purposes,
  • The right to self-archive the article,
  • The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Sabdariffarma).
  1. Co-Authorship

If the article was jointly prepared by more than one author, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. Sabdariffarma will not be held liable for anything that may arise due to the author(s) internal dispute. Sabdariffarma will only communicate with the corresponding author.

  1. Royalties

Being an open accessed journal and disseminating articles for free under the Creative Commons license term mentioned, author(s) aware that Sabdariffarma entitles the author(s) to no royalties or other fees. 

  1. Miscellaneous

Sabdariffarma will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. Sabdariffarma's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.